Isolated office hypertension: A 3-year follow-up study

被引:6
作者
Grandi, AM [1 ]
Solbiati, F [1 ]
Laurita, E [1 ]
Cassinerio, E [1 ]
Marchesi, C [1 ]
Piperno, F [1 ]
Maresca, A [1 ]
Guasti, L [1 ]
Venco, A [1 ]
机构
[1] Univ Insubria, Dept Clin Med, Varese, Italy
关键词
ambulatory BP monitoring; diastolic function; isolated office hypertension; left ventricular hypertrophy;
D O I
10.1080/08037050500331496
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The study aimed to evaluate, over a 3-year period, the progression towards sustained hypertension and left ventricular (LV) changes in patients with isolated office (IO) hypertension (office BP >140 and/or 90 mmHg, daytime BP <130/80 mmHg). After 3 years from the basal evaluation, 38 subjects with basal normal BP and 42 subjects with basal IO hypertension underwent a second 24-h BP monitoring and echocardiography; 19 patients of the basal IO hypertension group were not revaluated because they had already developed ambulatory hypertension and were on antihypertensive treatment. At the second evaluation, the 38 normotensive subjects had unchanged BP and LV parameters; 25 IO hypertensives have developed sustained hypertension. Considering them together with the 19 patients already treated, 72% of 61 IO hypertensives developed ambulatory hypertension over a 3-year period. The patients who subsequently developed hypertension differed from the group who did not only for lower basal values of LV diastolic parameters; all the patients with basal LV hypertrophy and/or preclinical diastolic impairment subsequently developed sustained hypertension. In conclusion, IO hypertensive patients show a high rate of progression towards sustained hypertension. Basal LV hypertrophy and/or preclinical diastolic dysfunction were the only markers of a greater risk of becoming hypertensives.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 29 条
[21]   STUDY OF LEFT-VENTRICULAR FUNCTION FROM DIGITIZED ECHOCARDIOGRAMS [J].
UPTON, MT ;
GIBSON, DG .
PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 20 (05) :359-384
[22]   Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study [J].
Vasan, RS ;
Larson, MG ;
Leip, EP ;
Kannel, WB ;
Levy, D .
LANCET, 2001, 358 (9294) :1682-1686
[23]  
Verdecchia, 1996, Blood Press Monit, V1, P217
[24]  
Verdecchia, 1998, Blood Press Monit, V3, P147
[25]   How can we use the results of ambulatory blood pressure monitoring in clinical practice? [J].
Verdecchia, P ;
Angeli, F .
HYPERTENSION, 2005, 46 (01) :25-26
[26]   VARIABILITY BETWEEN CURRENT DEFINITIONS OF NORMAL AMBULATORY BLOOD-PRESSURE - IMPLICATIONS IN THE ASSESSMENT OF WHITE COAT HYPERTENSION [J].
VERDECCHIA, P ;
SCHILLACI, G ;
BOLDRINI, F ;
ZAMPI, I ;
PORCELLATI, C .
HYPERTENSION, 1992, 20 (04) :555-562
[27]   WHITE COAT HYPERTENSION AND WHITE COAT EFFECT - SIMILARITIES AND DIFFERENCES [J].
VERDECCHIA, P ;
SCHILLACI, G ;
BORGIONI, C ;
CIUCCI, A ;
ZAMPI, I ;
GATTOBIGIO, R ;
SACCHI, N ;
PORCELLATI, C .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (08) :790-798
[28]   When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension [J].
Verdecchia, P ;
O'Brien, E ;
Pickering, T ;
Staessen, JA ;
Parati, G ;
Myers, M ;
Palatini, P .
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (01) :87-91
[29]   Properly defining white coat hypertension [J].
Verdecchia, P ;
Staessen, JA ;
White, WB ;
Imai, Y ;
O'Brien, ET .
EUROPEAN HEART JOURNAL, 2002, 23 (02) :106-109